First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of the first mRNA flu vaccine by the FDA is expected to impact public health across Ohio, potentially offering a new immunization option for residents in the upcoming flu season. Healthcare providers and public health departments, including those in Cuyahoga County, will likely incorporate this new vaccine into their seasonal flu prevention strategies.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.